Pilongo, Rudilyn T.
HRN: 26-64-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2025
CEFUROXIME 500MG (TAB)
03/22/2025
03/28/2025
PO
500mg
BID
S/P STAT CS With BTL
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes